HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Serum High-Mobility Group Box 1 and Heme Oxygenase-1 as Biomarkers in COVID-19 Patients at Hospital Admission.

Abstract
The careful monitoring of patients with mild/moderate COVID-19 is of particular importance because of the rapid progression of complications associated with COVID-19. For prognostic reasons and for the economic management of health care resources, additional biomarkers need to be identified, and their monitoring can conceivably be performed in the early stages of the disease. In this retrospective cross-sectional study, we found that serum concentrations of high-mobility group box 1 (HMGB1) and heme oxygenase-1 (HO-1), at the time of hospital admission, could be useful biomarkers for COVID-19 management. The study included 160 randomly selected recovered patients with mild to moderate COVID-19 on admission. Compared with healthy controls, serum HMGB1 and HO-1 levels increased by 487.6 pg/mL versus 43.1 pg/mL and 1497.7 pg/mL versus 756.1 pg/mL, respectively. Serum HO-1 correlated significantly with serum HMGB1, oxidative stress parameters (malondialdehyde (MDA), the phosphatidylcholine/lysophosphatidylcholine ratio (PC/LPC), the ratio of reduced and oxidative glutathione (GSH/GSSG)), and anti-inflammatory acute phase proteins (ferritin, haptoglobin). Increased heme catabolism/hemolysis were not detected. We hypothesize that the increase in HO-1 in the early phase of COVID-19 disease is likely to have a survival benefit by providing protection against oxidative stress and inflammation, whereas the level of HMGB1 increase reflects the activity of the innate immune system and represents levels within which the disease can be kept under control.
AuthorsIlijana Grigorov, Snežana Pejić, Ana Todorović, Dunja Drakulić, Filip Veljković, Jadranka Miletić Vukajlović, Katarina Bobić, Ivan Soldatović, Siniša Đurašević, Nebojša Jasnić, Sanja Stanković, Sofija Glumac, Violeta Mihailović-Vučinić, Branislava Milenković
JournalInternational journal of molecular sciences (Int J Mol Sci) Vol. 24 Issue 17 (Aug 24 2023) ISSN: 1422-0067 [Electronic] Switzerland
PMID37685970 (Publication Type: Journal Article)
Chemical References
  • Heme Oxygenase-1
  • HMGB1 Protein
  • Biomarkers
  • Glutathione
Topics
  • Humans
  • Heme Oxygenase-1
  • COVID-19
  • Cross-Sectional Studies
  • HMGB1 Protein
  • Retrospective Studies
  • Biomarkers
  • Glutathione
  • Hospitals

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: